SU5214 5 mg | Purity Not Available
TargetMol
SU5214
Search Results
Dihydroethidium 25 mg | 99.52%
TargetMol
Dihydroethidium
SU5214 25 mg | Purity Not Available
TargetMol
SU5214
Nilvadipine 100 mg | Purity Not Available
TargetMol
Nilvadipine, a calcium channel blocker (CCB), is utilized for treatment of hypertension.
More Information Supplier PageNilvadipine
Nilvadipine 10 mg | Purity Not Available
TargetMol
Nilvadipine, a calcium channel blocker (CCB), is utilized for treatment of hypertension.
More Information Supplier PageNilvadipine
Nilvadipine 50 mg | Purity Not Available
TargetMol
Nilvadipine, a calcium channel blocker (CCB), is utilized for treatment of hypertension.
More Information Supplier PageNilvadipine
Nilvadipine 200 mg | Purity Not Available
TargetMol
Nilvadipine, a calcium channel blocker (CCB), is utilized for treatment of hypertension.
More Information Supplier PageNilvadipine
NSC 23766 trihydrochloride 10 mg | 99.35%
TargetMol
NSC 23766 trihydrochloride (Rac1 Inhibitor) is an inhibitor of Rac GTPase targeting Rac activation by GEFs (IC50: ~50 μM); no inhibitory for the closely related targets, RhoA or Cdc42.
More Information Supplier PageNSC 23766 trihydrochloride
NSC 23766 trihydrochloride 25 mg | 99.35%
TargetMol
NSC 23766 trihydrochloride (Rac1 Inhibitor) is an inhibitor of Rac GTPase targeting Rac activation by GEFs (IC50: ~50 μM); no inhibitory for the closely related targets, RhoA or Cdc42.
More Information Supplier PageNSC 23766 trihydrochloride
NSC 23766 trihydrochloride 50 mg | 99.35%
TargetMol
NSC 23766 trihydrochloride (Rac1 Inhibitor) is an inhibitor of Rac GTPase targeting Rac activation by GEFs (IC50: ~50 μM); no inhibitory for the closely related targets, RhoA or Cdc42.
More Information Supplier PageNSC 23766 trihydrochloride